MARKET

RXRX

RXRX

Recursion Pharmaceuticals, Inc.
NASDAQ
7.58
-0.11
-1.43%
Opening 12:39 01/31 EST
OPEN
7.91
PREV CLOSE
7.69
HIGH
7.96
LOW
7.37
VOLUME
12.03M
TURNOVER
--
52 WEEK HIGH
15.74
52 WEEK LOW
5.60
MARKET CAP
2.96B
P/E (TTM)
-4.9456
1D
5D
1M
3M
1Y
5Y
1D
How Is The Market Feeling About Recursion Pharmaceuticals?
Benzinga · 1d ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
TipRanks · 1d ago
AI Pharma: 2 Paths to AI-Powered Drug Investment
NASDAQ · 3d ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
TipRanks · 4d ago
Weekly Report: what happened at RXRX last week (0120-0124)?
Weekly Report · 4d ago
Short Report: Bears bite into satellite stocks AST SpaceMobile, Telesat
TipRanks · 5d ago
Stargate Project’s healthcare winners: AI-led biotechs and Metagenomi
Seeking Alpha · 6d ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
TipRanks · 01/24 16:25
More
About RXRX
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. REC-994 is an orally bioavailable, superoxide scavenger small molecule being development for the treatment of symptomatic cerebral cavernous malformation (CCM). REC-2282 for the potential treatment of neurofibromatosis type 2. REC-3964 for the prevention of recurrent Clostridioides difficile infection.

Webull offers Recursion Pharmaceuticals Inc stock information, including NASDAQ: RXRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXRX stock methods without spending real money on the virtual paper trading platform.